Document is current
Any future updates will be listed below
-
Authors
Lattanzi, Simona http://orcid.org/0000-0001-8748-0083
Canafoglia, Laura
Canevini, Maria Paola
Casciato, Sara
Cerulli Irelli, Emanuele
Chiesa, Valentina
Dainese, Filippo
De Maria, Giovanni
Didato, Giuseppe
Falcicchio, Giovanni
Fanella, Martina
Ferlazzo, Edoardo
Gangitano, Massimo
Giorgi, Filippo Sean
La Neve, Angela
Mecarelli, Oriano
Montalenti, Elisa
Morano, Alessandra
Piazza, Federico
Pulitano, Patrizia
Quarato, Pier Paolo
Ranzato, Federica
Rosati, Eleonora
Tassi, Laura
Di Bonaventura, Carlo
,
Alicino, Angela
Ascoli, Michele
Assenza, Giovanni
Avorio, Federica
Badioni, Valeria
Banfi, Paola
Bartolini, Emanuele
Basili, Luca M.
Belcastro, Vincenzo
Beretta, Simone
Berto, Irene
Biggi, Martina
Billo, Giuseppe
Boero, Giovanni
Bonanni, Paolo
Bongiorno, Jole
Brigo, Francesco
Caggia, Emanuele
Cagnetti, Claudia
Calvello, Carmen
Cesnik, Edward
Chianale, Gigliola
Ciampanelli, Domenico
Ciuffini, Roberta
Cocito, Dario
Colella, Donato
Contento, Margerita
Costa, Cinzia
Cumbo, Eduardo
D’Aniello, Alfredo
Deleo, Francesco
DiFrancesco, Jacopo C.
Di Gennaro, Giancarlo
Di Giacomo, Roberta
Di Liberto, Alessandra
Domina, Elisabetta
Dono, Fedele
Durante, Vania
Elia, Maurizio
Estraneo, Anna
Evangelista, Giacomo
Faedda, Maria T.
Failli, Ylenia
Fallica, Elisa
Fattouch, Jinane
Ferrari, Alessandra
Ferreri, Florinda
Fisco, Giacomo
Fonti, Davide
Fortunato, Francesco
Foschi, Nicoletta
Francavilla, Teresa
Galli, Rosita
Gazzina, Stefano
Giallonardo, Anna T.
Giuliano, Loretta
Habetswallner, Francesco
Izzi, Francesca
Kassabian, Benedetta
Labate, Angelo
Luisi, Concetta
Magliani, Matteo
Maira, Giulia
Mari, Luisa
Marino, Daniela
Mascia, Addolorata
Mazzeo, Alessandra
Meletti, Stefano
Nilo, Annacarmen
Orlando, Biagio
Paladin, Francesco
Pascarella, Maria G.
Pastori, Chiara
Pauletto, Giada
Peretti, Alessia
Perri, Gabriella
Pezzella, Marianna
Piccioli, Marta
Pignatta, Pietro
Pilolli, Nicola
Pisani, Francesco
Pisani, Laura R.
Placidi, Fabio
Pollicino, Patrizia
Porcella, Vittoria
Pradella, Silvia
Puligheddu, Monica
Quadri, Stefano
Quintas, Rui
Renna, Rosaria
Rizzo, Giada Ricciardo
Rum, Adriana
Salamone, Enrico M.
Savastano, Ersilia
Sessa, Maria
Stokelj, David
Tartara, Elena
Tombini, Mario
Tumminelli, Gemma
Vaudano, Anna E.
Ventura, Maria
Viganò, Ilaria
Viglietta, Emanuela
Vignoli, Aglaia
Villani, Flavio
Zambrelli, Elena
Zummo, Lelia
- License Information
-
More Information
Article History
Accepted: 28 February 2022
First Online: 28 March 2022
Change Date: 24 July 2022
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: Open access funding provided by Marche Polytechnic University within the CRUI-CARE Agreement. No funding was received for the conduct of this study. Open access funding was provided by Università Politecnica delle Marche within the CRUI-CARE Agreement.
: SL has received speaker’s or consultancy fees from Angelini, Eisai, GW Pharmaceuticals, and UCB Pharma, and has served on advisory boards for Angelini, Arvelle Therapeutics, Bial, and GW Pharmaceuticals. LC has received consultancy fees from Eisai. MPC has received speaker’s or consultancy fees from Bial, Eisai, Italfarmaco, Sanofi, and UCB Pharma. SC has participated in pharmaceutical industry-sponsored symposia for Eisai, UCB Pharma, and Lusofarmaco. VC has received speaker’s or consultancy fees from Eisai and UCB Pharma. ALN has received speaker’s or consultancy fees from Eisai, Mylan, Bial, Sanofi, and UCB Pharma. PP has received consulting fees or speaker honoraria from UCB Pharma and Eisai. PPQ has participated in pharmaceutical industry-sponsored clinical trials and symposia for UCB Pharma. FR has received speaker’s fees from Eisai, UCB, and Livanova. ER has received fees for participation in advisory board or scientific consultation from Eisai, GW Pharmaceuticals, Bial, and UCB Pharma. LT has received speaker’s or consultancy fees from Arvelle Therapeutics, Eisai, and UCB Pharma. CDB has received consulting fees or speaker honoraria from UCB Pharma, Eisai, GW Pharmaceuticals, Bial, and Lusopharma. ECI, FD, GDM, GD, GF, MF, EF, MG, FSG, OM, EM, AM, and FP have no conflicts of interest to declare.
: This study was approved by the ethical committees at all participating sites and was conducted in accordance with the Declaration of Helsinki.
: Informed consent was obtained from every patient and/or their parent or legal representative.
: Not applicable.
: Anonymized data will be shared at the request of any qualified investigator.
: Not applicable.
: SL designed and conceptualized the study, coordinated and supervised the data collection, carried out the data analyses, and drafted the manuscript. VC, EF, ALN, and EM designed and conceptualized the study, and coordinated and supervised the data collection. LC, MPC, SC, ECI, FD, GDM, GD, GF, MF, MG, FSG, OM, AM, FP, PP, PPQ, FR, ER, and LT were involved in the acquisition of data. CDB designed and conceptualized the study, coordinated and supervised the data collection, and drafted the manuscript. All authors critically revised the manuscript for important intellectual content. All authors approved the final manuscript for submission and agree to be accountable for all aspects of the work.
